Results 71 to 80 of about 90,671 (304)

3D printing is a transformative technology in congenital heart disease [PDF]

, 2018
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child.
Anwar, Anwar, Barach, Bernhard, Bhatla, Biglino, Biglino, Binder, Boneva, Borrello, Botto, Brown, Bucher, Byrne, Chaowu, Conti, Costello, Dearani, Deferm, Duan, Duan, Erikssen, Fan, Farooqi, Farooqi, Farooqi, Fleming, Fukunishi, Garekar, Gaynor, Gentles, Giamberti, Giannopoulos, Giroud, Gosnell, Grant, Green, Hadeed, Hermsen, Hoffman, Holst, Holst, Hu, Jacobs, Jana, Javan, Jonas, Kappetein, Kapur, Khairy, Kiraly, Kirklin, Kolli, Kotsis, Kung, Lee, Lee, Little, Lloyd-Jones, Mahle, Mahmood, Mannoor, Maragiannis, Markert, Markstedt, Mashari, Meier, Michael, Mitsouras, Moons, Moore, Morrison, Muraru, Ngan, Noecker, Olivieri, Olivieri, O’Brien, O’Neill, Pentecost, Poterucha, Randazzo, Rehder, Riesenkampff, Ripley, Rodriguez-Paz, Ryan, Saeed, Samuel, Santos dos, Schievano, Schmauss, Shah, Smith, Sodian, Sodian, Sutcliffe, Tabriz, Tack, Taylor, Valverde, VanKoevering, Vukicevic, Vukicevic, Vukicevic, Wang, Wang, Warnes, Warnes, Warnes, Whitlock, Wilasrusmee, Williams, Witschey, Yoo, Yoo, Zopf, Zweifel   +117 more
core   +3 more sources

Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.

European Heart Journal, 2020
AIMS Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are increasingly performed. There are no data on long-term outcomes after aortic ViV.
S. Bleiziffer, M. Simonato, J. Webb, J. Rodés‐Cabau, P. Pibarot, R. Kornowski, S. Windecker, M. Erlebach, A. Duncan, M. Seiffert, A. Unbehaun, C. Frerker, L. Conzelmann, H. Wijeysundera, Won-Keun Kim, M. Montorfano, A. Latib, D. Tchétché, A. Allali, M. Abdel-Wahab, K. Orvin, S. Stortecky, H. Nissen, A. Holzamer, M. Urena, L. Testa, M. Agrifoglio, B. Whisenant, J. Sathananthan, M. Napodano, A. Landi, C. Fiorina, A. Zittermann, Verena Veulemans, J. Sinning, F. Saia, S. Brecker, P. Presbitero, O. de Backer, L. Søndergaard, G. Bruschi, L. Franco, A. Petronio, M. Barbanti, A. Cerillo, K. Spargias, J. Schofer, Mauricio G. Cohen, A. Muñoz‐Garcia, A. Finkelstein, Matti Adam, V. Serra, R. Teles, D. Champagnac, A. Iadanza, Piotr Chodór, H. Eggebrecht, R. Welsh, A. Caixeta, S. Salizzoni, A. Dager, V. Auffret, A. Cheema, T. Ubben, M. Ancona, T. Rudolph, J. Gummert, E. Tseng, S. Noble, M. Bunc, D. Roberts, M. Kass, Anuj Gupta, M. Leon, D. Dvir   +74 more
semanticscholar   +1 more source

Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) has gained interest as concomitant coronary artery disease (CAD) is now often treated conservatively before TAVR, and TAVR is increasingly used in younger patients with longer life expectancies. Therefore, more contemporary data on PCI after
Hugo M. Aarts, Kimberley I. Hemelrijk, Gijs M. Broeze, Steven A. Muller, Lineke Derks, Ronak Delewi, Michiel Voskuil, the Transcatheter Heart Intervention and Percutaneous Coronary Intervention registration committees of the Netherlands Heart Registration   +7 more
wiley   +1 more source

Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis. [PDF]

, 2016
The safety and effectiveness of the fully repositionable LOTUS valve system as compared with the balloon-expandable Edwards SAPIEN 3 prosthesis for the treatment of aortic stenosis has not been evaluated to date.
Ferrari, E., Grünenfelder, J., Heg, D., Huber, C., Jeger, R., Maisano, F., Nietlispach, F., Noble, S., Pilgrim, T., Roffi, M., Stortecky, S., Toggweiler, S., Tueller, D., Wenaweser, P., Windecker, S.   +14 more
core   +4 more sources

Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

European Journal of Heart Failure, 2021
Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve implantation (TAVI) are at increased risk of developing heart failure (HF) within first months of intervention.
I. Amat-Santos, J. P. Sánchez-Luna, E. Abu-Assi, M. Melendo-Viu, I. Cruz-González, L. Nombela‐Franco, Antonio J. Muñoz‐Garcí, S. G. Blas, J. M. T. Torre Hernández, R. Romaguera, A. Sanchez-Recalde, J. L. Díez-Gil, D. Lopez-Otero, Livia Gheorge, B. Ibáñez, A. Iñíguez-Romo, S. Raposeiras-Roubín   +16 more
semanticscholar   +1 more source

Commissural Misalignment Following Valve‐in‐Valve Transcatheter Aortic Valve Implantation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Data on commissural misalignment (CMA) during valve‐in‐valve transcatheter aortic valve implantation (ViV‐TAVI) for valve failure after surgical aortic valve replacement (SAVR) is scarce. Aims To study the impact of CMA on clinical and hemodynamic outcomes following ViV‐TAVI for failed SAVR.
Matthias Raschpichler, Johannes Rotta Detto Loria, Vivek Patel, Thilo Noack, Karoline Nüsser, Oliver Dumpies, Dhairya Patel, Takashi Nagasaka, Prateek Madaan, Aakriti Gupta, Holger Thiele, Michael A. Borger, Raj Makkar, Mohamed Abdel‐Wahab   +13 more
wiley   +1 more source

Transcatheter aortic valve implantation [PDF]

Kardiologia Polska, 2017
Maciej, Dąbrowski, Ariel, Finkelstein, Adam, Witkowski   +2 more
  +6 more sources

Incidenza, cause e predittori di reospedalizzazione in pazienti sottoposti ad impianto transcatetere di valvola aortica [PDF]

, 2017
La frequenza, le cause e i predittori di reospedalizzazione dopo impianto transcatetere di valvola aortica sono stati analizzati in una popolazione di 900 pazienti inclusi nel Bern TAVI Registry tra Agosto 2007 e Giugno 2014.
Franzone, Anna
core   +1 more source

Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub‐Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Physical decline after transcatheter aortic valve implantation (TAVI) is associated with worse outcomes. However, data on post‐TAVI extremity function are limited. This sub‐study of the TAVI XS trial aimed to assess extremity function after transfemoral TAVI, evaluate functional decline, compare outcomes between upper‐and lower ...
Geert A. A. Versteeg, Maxim J. P. Rooijakkers, Kimberley I. Hemelrijk, Pieter J. Vlaar, Daniël C. Overduin, Marleen H. van Wely, Hugo M. Aarts, Dirk‐Jan van Ginkel, Niels A. Stens, Lokien X. van Nunen, Robert Jan van Geuns, Leen A. F. M. van Garsse, Guillaume S. C. Geuzebroek, Michel W. A. Verkroost, Aysun Cetinyurek‐Yavuz, Robin H. Heijmen, Dick H. J. Thijssen, Jurrien M. ten Berg, Pim A. L. Tonino, Ronak Delewi, Niels van Royen   +20 more
wiley   +1 more source

Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. [PDF]

, 2017
Aims: The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve implantation (TAVI) with a self-expanding bioprosthesis in real-world patients with symptomatic, severe aortic stenosis at high surgical risk for ...
Adams, Axel Linke, Barbanti, Bosmans, Brecker, Corrado Tamburino, Deeb, Duncan, Egbe, Grube, Jia Guo, Johan Bosmans, Joint Task Force on the Management of Valvular Heart Disease of the European Society of (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Kapadia, Kappetein, Kleiman, Leon, Leon, Leon, Linke, Mack, Makkar, Makkar, Peter Wenaweser, Piazza, Popma, Reardon, Sabine Bleiziffer, Sondergaard, Sondergaard, Stephen Brecker, Ulrich Gerckens, Van Belle, Yakubov   +33 more
core   +1 more source